Goldman Sachs Sees 2025 Dividend Growth and 4 High-Yield Passive Income Stocks Are Strong Buys24/7 Wall Street • 03/16/25
Pfizer Is Facing A First-Quarter Slowdown. Is Pfizer Stock Now A Sell?Investors Business Daily • 03/14/25
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEPBusiness Wire • 03/12/25
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In TrialBenzinga • 03/11/25
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical TrialGlobeNewsWire • 03/11/25
Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?Zacks Investment Research • 03/10/25
2 Attractively Priced, High Yield Stocks For Income Durability As The Market Hits New HighsSeeking Alpha • 03/05/25
Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the USBusiness Insider • 03/04/25